This non-prescription test allows users to perform and get results themselves without a medical provider or laboratory needed.
The first over-the-counter at-home diagnostic test for coronavirus disease 2019 (COVID-19) was granted emergency use authorization (EUA) by the US Food and Drug Administration (FDA) yesterday. The EUA was for the Ellume COVID-19 Home Test.
FDA Commissioner Stephen M. Hahn, MD, called the EUA “a major milestone in diagnostic testing for COVID-19. By authorizing a test for over-the-counter use, the FDA allows it to be sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes.”
The FDA granted an EUA last month to Lucira Health for it’s at-home, self-administered COVID test which can be purchased with a prescription. Since the beginning of the pandemic, the agency has authorized more than 225 COVID-19 diagnostic tests, including more than 25 tests that allow for home collection of samples, which are then sent to a lab for testing.
“As we continue to authorize additional tests for home use, we are helping expand Americans’ access to testing, reducing the burden on laboratories and test supplies, and giving Americans more testing options from the comfort and safety of their own homes,” Hahn said.
The test may prove especially useful during this second wave of COVID-19.
According to the COVID Tracking Project, yesterday was a record-breaking day in terms of people being hospitalized for COVID-19: 112,816 people were hospitalized for COVID yesterday, the most ever. The next four highest days for hospitalization? They are December 14, 13, 12, and 11—the four previous days.
According to Johns Hopkins University, there were 189,357 confirmed cases of COVID-19 yesterday while 3019 people died from the disease. That’s the third highest one-day death toll for the disease in the United States since the pandemic began.
Overall, in the United States there have been nearly 17 million confirmed cases of COVID-19. And, in the United States, over 300,000 people have died from the disease. In the world, there have been over 70 million confirmed cases of COVID-19. And, in the world, over 1.6 million people have died from the disease.
This story originally appeared in Contagion®.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.